AstraZeneca, Ionis Win A Key US FDA Approval With Wainua For ATTR Polyneuropathy

Drug Launches In January Under Co-Commercialization Deal

FDA Approved text on white notepad paper near folders
Wainua is the first patient-administered drug for ATTR-PN • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from New Products

More from Scrip